Übersetzung für 'vasoactive' von Englisch nach Deutsch

vasoactive {adj}

vasoaktivmed.

vasoactive {adj} [drugs]

gefäßverändernd [Medikamente]med.

---

Werbung

vasoactive intestinal peptide <VIP>

vasoaktives intestinales Peptid {n} <VIP>biochem.

vasoactive intestinal polypeptide <VIP>

vasoaktives intestinales Polypeptid {n} <VIP>biochem.

• Aviptadil is an injectable synthetic formulation of human vasoactive intestinal peptide (VIP).
• Buflomedil, sold under the brand name Loftyl, is a vasoactive drug used to treat claudication or the symptoms of peripheral arterial disease.
• In gastrointestinal smooth muscle, the slow-wave threshold can be altered by input from endogenous and exogenous innervation, as well as excitatory (acetylcholine and Substance P) and inhibitory (vasoactive intestinal peptide and nitric oxide) compounds.
• Glucagon/gastric inhibitory polypeptide/secretin/vasoactive intestinal peptide hormones are a family of evolutionarily related peptide hormones that regulate activity of G-protein-coupled receptors from the secretin receptor family.
• VPAC1 is a receptor for vasoactive intestinal peptide (VIP), a small neuropeptide.

  ---

• Hormones secreted include somatostatin, motilin, cholecystokinin, neurotensin, vasoactive intestinal peptide, and enteroglucagon.
• Vasoactive drugs are typically administered using a volumetric infusion device (IV pump).
• The resulting ischemia prompts further release of vasoactive substances including prostaglandins, free radicals, and thrombotic/mitotic growth factors, completing a vicious cycle of inflammatory changes.
• Vasoactive intestinal peptide, also known as vasoactive intestinal polypeptide or VIP, is a peptide hormone that is vasoactive in the intestine.
• The fibroma cavernosum or angiofibroma, consists of many often dilated vessels, it is a vasoactive tumor occurring almost exclusively in adolescent males.

  ---

• LBT-3627 is an experimental peptide drug derived from vasoactive intestinal peptide (VIP) that can change the behavior of immune cells so they protect dopamine-producing cells rather than attacking them.
• The sphincter of Oddi is relaxed by the hormone cholecystokinin via vasoactive intestinal peptide.
• The use of vasoactive agents for people with pulmonary hypertension with left heart disease or hypoxemic lung diseases may cause harm and unnecessary expense.
• Blisters occur specifically at vasoactive pressure sites between 48 to 72 hours after the start of unconsciousness.